PharmAthene, Inc.

CLOSED

马里兰州安妮阿伦德尔县, 马里兰州, United Stateswww.pharmathene.comPrivate51–100 employeesEstablished: 2001-01-01

Part of Alturas Minerals Corp

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Completed

60.0%

Suspended

20.0%

Terminated

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects

Phase 1

Completed

interventional

Dec 201028 participants

Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use

Phase 1

Completed

interventional

Jul 20105 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

PharmAthene, Inc.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (5)

Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects

Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use

Ph1 Study of Valortim and Ciprofloxacin in Humans

Ph1 Study of Valortim and Doxycycline in Humans

First Time in Human Study of Protexia

Approvals

News